{"nct_id":"NCT06799000","title":"A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-01-31","start_date_type":"ACTUAL","primary_completion_date":"2028-09-21","primary_completion_date_type":"ESTIMATED","completion_date":"2028-10-20","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}